Home RxNorm 1536142 120 ACTUAT mometasone furoate 0.1 MG/ACTUAT Metered Dose Inhaler Drug identity information. FDA.report links public drug records from RxNav, DailyMed, FDA NDC, Drugs@FDA, and related public sources where available. This page is informational only and is not medical, prescribing, or regulatory advice.
RxCUI 1536142
RxNorm name 120 ACTUAT mometasone furoate 0.1 MG/ACTUAT Metered Dose Inhaler
Display name Mometasone (Inhalant)
Full name 120 ACTUAT mometasone furoate 0.1 MG/ACTUAT Metered Dose Inhaler
Term type SCD
Status Active
Strength 100 mcg/puff
Dose form MDI 120 puff
Route Inhalant
Updated 2026-10-17 23:56:26 RxNorm Status History#
Status Active
Source RXNORM
Current YES
Release start 062014
Active start 062014
Multiple ingredient NO
Branded NO Ingredients And Strength# Ingredient, Strength, Base table Ingredient Strength Base Basis of strength mometasone furoate 100 MCG / 1 ACTUAT mometasone mometasone furoate
Derived Ingredient Concepts# Ingredient, RxCUI table Ingredient RxCUI mometasone 108118
RxNav Current And Historical NDCs# RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.
No records found.
UNII Substances# UNII substance links page 1 of 1 · 0 matching rows.
No records found.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings# unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.
Set ID, RxNorm mappings, Terms table Set ID RxNorm mappings Terms SPL version Label Effective 0c6d63da-41bc-4894-bead-198e66c848ac mometasone furoate 100 MCG/INHAL Metered Dose Inhaler, 120 ACTUAT [PSN] · 120 ACTUAT mometasone furoate 0.1 MG/ACTUAT Metered Dose Inhaler [SCD] · 120 ACTUAT mometasone furoate 100 MCG/ACTUAT Metered Dose Inhaler [SY] 3 7 These highlights do not include all the information needed to use ASMANEX HFA safely and effectively. See full prescribing information for ASMANEX HFA. ASMANEX ® HFA (mometasone furoate) inhalation aerosol, for oral inhalation use Initial U.S. Approval: 1987 20260122
Drug Classes# Source, Class ID, Class table Source Class ID Class Type Relationship Drug concept ATC R01AD Corticosteroids ATC1-4 mometasone ATC D07AC Corticosteroids, potent (group III) ATC1-4 mometasone ATC D07XC Corticosteroids, potent, other combinations ATC1-4 mometasone ATC R03BA Glucocorticoids ATC1-4 mometasone FDASPL N0000175576 Corticosteroid EPC has_epc mometasone FDASPL N0000175450 Corticosteroid Hormone Receptor Agonists MOA has_moa mometasone MEDRT D000068656 Mometasone Furoate CHEM has_ingredient mometasone MEDRT D000068656 Mometasone Furoate CHEM has_ingredient mometasone furoate MEDRT D003881 Dermatomycoses DISEASE ci_with mometasone MEDRT D003881 Dermatomycoses DISEASE ci_with mometasone furoate MEDRT D004342 Drug Hypersensitivity DISEASE ci_with mometasone furoate MEDRT D004342 Drug Hypersensitivity DISEASE ci_with mometasone MEDRT D005148 Facial Dermatoses DISEASE may_treat mometasone furoate MEDRT D005148 Facial Dermatoses DISEASE may_treat mometasone MEDRT D005533 Foot Dermatoses DISEASE may_treat mometasone MEDRT D005533 Foot Dermatoses DISEASE may_treat mometasone furoate MEDRT D006229 Hand Dermatoses DISEASE may_treat mometasone MEDRT D006229 Hand Dermatoses DISEASE may_treat mometasone furoate MEDRT D006561 Herpes Simplex DISEASE ci_with mometasone furoate MEDRT D006561 Herpes Simplex DISEASE ci_with mometasone MEDRT D006562 Herpes Zoster DISEASE ci_with mometasone furoate MEDRT D006562 Herpes Zoster DISEASE ci_with mometasone MEDRT D006967 Hypersensitivity DISEASE ci_with mometasone furoate MEDRT D007249 Inflammation DISEASE may_treat mometasone furoate MEDRT D007249 Inflammation DISEASE may_treat mometasone MEDRT D007868 Leg Dermatoses DISEASE may_treat mometasone furoate MEDRT D007868 Leg Dermatoses DISEASE may_treat mometasone MEDRT D011537 Pruritus DISEASE may_treat mometasone furoate MEDRT D011537 Pruritus DISEASE may_treat mometasone MEDRT D012221 Rhinitis, Allergic, Perennial DISEASE may_treat mometasone MEDRT D012221 Rhinitis, Allergic, Perennial DISEASE may_treat mometasone furoate MEDRT D012536 Scalp Dermatoses DISEASE may_treat mometasone MEDRT D012536 Scalp Dermatoses DISEASE may_treat mometasone furoate MEDRT D014382 Tuberculosis, Cutaneous DISEASE ci_with mometasone MEDRT D014382 Tuberculosis, Cutaneous DISEASE ci_with mometasone furoate MEDRT N0000000159 Glucocorticoid Receptor Agonists MOA has_moa mometasone MEDRT N0000000159 Glucocorticoid Receptor Agonists MOA has_moa mometasone furoate MEDRT N0000000134 Lipoxygenase Inhibitors MOA has_moa mometasone MEDRT N0000000134 Lipoxygenase Inhibitors MOA has_moa mometasone furoate MEDRT N0000008681 Decreased Leukotriene Activity PE has_pe mometasone MEDRT N0000008681 Decreased Leukotriene Activity PE has_pe mometasone furoate MEDRT N0000008834 Decreased Prostaglandin Activity PE has_pe mometasone MEDRT N0000008834 Decreased Prostaglandin Activity PE has_pe mometasone furoate MEDRT N0000008841 Decreased Protein Synthesis PE has_pe mometasone MEDRT N0000008841 Decreased Protein Synthesis PE has_pe mometasone furoate MEDRT N0000009004 Decreased Thromboxane Activity PE has_pe mometasone MEDRT N0000009004 Decreased Thromboxane Activity PE has_pe mometasone furoate MEDRT N0000009908 Vasoconstriction PE has_pe mometasone MEDRT N0000009908 Vasoconstriction PE has_pe mometasone furoate
Properties# Category, Property, Value table Category Property Value ATTRIBUTES AVAILABLE_STRENGTH 0.1 MG/ACTUAT (expressed as mometasone furoate) ATTRIBUTES GENERAL_CARDINALITY SINGLE ATTRIBUTES HUMAN_DRUG US ATTRIBUTES QUANTITY 120 ACTUAT ATTRIBUTES RXNAV_HUMAN_DRUG US ATTRIBUTES SCHEDULE 0 CODES VUID 4033967 NAMES Prescribable Synonym mometasone furoate 100 MCG/INHAL Metered Dose Inhaler, 120 ACTUAT SOURCES Source Veterans Health Administration National Drug File